Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check35 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.3%

- Check49 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2, and removed the Back to Top element. No core content, pricing, stock, or schedule information was affected.SummaryDifference0.7%

- Check56 days agoChange DetectedThe web page has updated its version from v3.0.0 to v3.0.1 and has changed the date from 2024-10-15 to 2025-09-02. Additionally, a section titled 'Study Status Contacts/Locations' has been added.SummaryDifference2%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference17%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.